Ahead of World Diabetes Day (November 14), PharmEasy, one of India’s leading healthcare platforms, has released its latest report titled “Diabetes: The Silent Killer Sweeping Across India.” Based on data from January 2021 to September 2025, the study analyzed over 4 million diagnostic reports and 19 million medicine orders across 29 states and Union Territories. The findings paint a concerning picture of India’s escalating diabetes burden and underline the urgent need for early detection and sustained management.
Over Half of Tested Individuals Show Blood Sugar Irregularities
According to the report, nearly one in three HbA1c test results fall within the diabetic range, while one in four individuals exhibit signs of prediabetes. Together, this means that more than half of those tested show some level of blood sugar abnormality, underscoring the widespread nature of the disease.
“At PharmEasy, we see firsthand how early testing and awareness can change lives,” said Gaurav Verma, Head of B2C, PharmEasy (API Holdings). “This report is not just data — it is a call to action. One in two people tested show high blood sugar levels, and millions remain unaware of their risk. Through accessible testing, continuous monitoring, and medical guidance, we aim to empower every Indian to take charge of their health. Awareness, timely diagnosis, and prevention must go hand in hand to curb this silent epidemic.”
A Silent Epidemic Spreading Across Age Groups
PharmEasy’s findings reveal that younger adults are increasingly affected by diabetes. Even among individuals under 30 years, a significant proportion showed high blood sugar levels. The condition peaks after age 60, with 8 in 10 individuals testing diabetic or prediabetic. Notably, blood sugar levels start rising sharply from age 30, indicating that lifestyle and dietary factors begin impacting health much earlier.
“One of the most alarming trends is the shifting age profile of diabetes,” explained Dr. Animesh Choudhary, MBBS, MD. “This means that complications such as heart disease, kidney failure, and vision loss are appearing decades earlier. Diabetes prevention must begin in childhood, with healthy eating, regular physical activity, and emotional well-being. These early habits are key to reducing future risk.”
Gender Differences and Regional Variations
As per the press release, the report also reveals clear gender-based differences in blood sugar levels and insulin resistance — a key factor in diabetes development. About 51.9% of men and 45.43% of women tested showed high blood sugar, while 58% of all users exhibited insulin resistance.
Men tend to develop diabetes earlier due to higher abdominal fat accumulation, whereas women show a sharp rise post-menopause as estrogen protection declines.
Regionally, southern and coastal states show the highest prevalence. Puducherry (63%), Odisha (61%), Tamil Nadu (56%), and Goa (54%) reported the highest blood sugar levels, while states like Himachal Pradesh (41%) showed comparatively lower numbers. These variations reflect a complex interplay of dietary patterns, lifestyle choices, and healthcare access.
Chronic Disease Management on the Rise
PharmEasy’s medicine order data highlights India’s growing dependence on chronic medications. Diabetes medicines now account for over one-third of all PharmEasy orders, rising from 25% in 2021 to 34% in 2024. This surge reflects how long-term disease management has become a dominant part of healthcare consumption in the country.
The Hidden Impact Beyond Blood Sugar
PharmEasy’s analysis reveals that diabetes often affects multiple organ systems simultaneously. Among individuals with high blood sugar levels:
- 1 in 4 also showed thyroid abnormalities (mostly hypothyroidism).
- 1 in 3 had liver function issues.
- Nearly half showed signs of kidney impairment.
- About 90% had abnormal lipid profiles, raising their risk of heart disease.
These findings stress the importance of comprehensive screening for those diagnosed with diabetes — including tests for liver, kidney, thyroid, and heart health — to detect and prevent related complications.
Early Intervention Shows Measurable Improvements
Encouragingly, the report highlights that timely intervention can reverse early signs of diabetes. Among individuals who retested within six months, 22% returned to normal sugar levels, while 61% maintained stable readings. This demonstrates that consistent monitoring, appropriate medication, and lifestyle changes can significantly improve long-term outcomes.
A Call for Awareness and Action
The PharmEasy Diabetes Report reaffirms that small, consistent steps can make a big difference. Regular testing, preventive care, and lifestyle modifications can help millions of Indians detect diabetes early and manage it effectively.
As the nation prepares to mark World Diabetes Day, PharmEasy’s message is clear — awareness, early intervention, and proactive health management are the strongest tools to stop this silent epidemic from sweeping across India.